{
    "Trade/Device Name(s)": [
        "ADAMS A1c HA-8180V",
        "Calibrator 80"
    ],
    "Submitter Information": "ARKRAY, INC.",
    "510(k) Number": "K162822",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131580",
        "K071132"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PDJ",
        "LCP",
        "JIT"
    ],
    "Summary Letter Date": "June 29, 2017",
    "Summary Letter Received Date": "May 31, 2017",
    "Submission Date": "May 30, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1373",
        "21 CFR 864.7470",
        "21 CFR 862.1150"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay",
        "Calibrator"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Hemolysate"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADAMS A1c HA-8180V"
    ],
    "Method(s)/Technology(ies)": [
        "Ion Exchange High Performance Liquid Chromatography (HPLC)"
    ],
    "Methodologies": [
        "Chromatography",
        "Colorimetric detection"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ADAMS A1c HA-8180V automated analyzer and Calibrator 80 for quantitation of hemoglobin A1c in whole blood and hemolysate using ion exchange HPLC.",
    "Indications for Use Summary": "Quantitative determination of hemoglobin A1c in human whole blood and hemolysate samples to aid in diabetes diagnosis, identification of risk, and monitoring of long-term blood glucose control; calibrator is for system calibration.",
    "fda_folder": "Clinical Chemistry"
}